Categories: News

Conference Call on Report on Operations 2021

GOTHENBURG, SWEDEN / ACCESSWIRE / January 12, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)

Invitation to attend XVIVO’s conference call regarding the presentation of the Report on operations 2021. The presentation will be held in English.

Time: Thursday, January 27, 2022 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https://onlinexperiences.com/Launch/QReg/ShowUUID=79FB5586-A7E7-4ADE-8CED-0EFB336BAB64 .

Phone numbers to the conference:
Sweden: +46 856642651 PIN: 81618398#
UK: +44 3333000804 PIN: 81618398#
US: +1 6319131422 PIN: 81618398#
Conference name: XVIVO Group Report on Operations Q4 2021

Participants from XVIVO:
Dag Andersson, CEO
Kristoffer Nordström, CFO

The press release for XVIVO’s Report on operations 2021 will be released on January 27, 2022 at 7:30 a.m. CET.

Before the conference call, the presentation will be available at the company web page, https://www.xvivoperfusion.com/corporate/financial-presentations/earnings-calls/

XVIVO Perfusion AB (publ)

For further information, please contact:

Dag Andersson, CEO, +46 76 643 30 31, e-mail: dag.andersson@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com

About Us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.

Attachments

Conference call on Report on operations 2021

SOURCE: XVIVO Perfusion AB

View source version on accesswire.com:
https://www.accesswire.com/683115/Conference-Call-on-Report-on-Operations-2021

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

3 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

5 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

5 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

5 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

5 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

5 hours ago